• Jonathan D Cohen, Eyal Katvan, and Tamar Ashkenazi.
• National Transplant Center, Ministry of Health, Tel Aviv, Israel.
• Isr Med Assoc J. 2022 Aug 1; 24 (8): 524-528.

BackgroundChanges accommodating requirements of religious authorities in Israel resulted in the Brain and Respiratory Death Determination Law (BRDDL), which came into effect in 2009. These included considering patient wishes regarding the brain respiratory death determination (BRDD), mandatory performance of apnea and ancillary testing, establishment of an accreditation committee, and accreditation required for physicians performing BRDD.ObjectivesTo assess the impact of the legislation from 2010-2019.MethodsData collected included the number of formal BRDDs and accredited physicians. Obstacles to declaring brain death and interventions applied were identified.ResultsObstacles included lack of trained physicians to perform BRDD and interpret ancillary test results, inability to perform apnea or ancillary testing, and non-approach to next-of-kin objecting to BRDD. Interventions included physician training courses, additional ancillary test options, and legal interpretation of patient wishes for non-determination of BRD. As a result, the number of non-determinations related to next-of-kin objecting decreased (26 in 2010 to 5 in 2019), inability to perform apnea or ancillary testing decreased (33 in 2010 to 2 in 2019), and number of physicians receiving accreditation increased (210 in 2010 to 456 in 2019). Last, the consent rate for organ donation increased from 49% to 60% in 2019.ConclusionsThe initial decrease in BRDDs has reversed, thus enabling more approaches for organ donation. The increased consent rate may reflect in part the support of the rabbinate and confidence of the general public that BRDD is performed and monitored according to strict criteria.

8 keywords...

hide…